MMIT - Managed Markets Insight & Technology

  • Home
  • MMIT - Managed Markets Insight & Technology

MMIT - Managed Markets Insight & Technology We leverage technology, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered.

20/02/2026

Free-text plan names are like junk drawers. You can dig through them… but wouldn’t you rather know exactly what’s inside?

With MMIT’s BIN/PCN/Group mapping, you gain structure, clarity, and confidence in coverage insights.

Meet with MMIT to learn more. Because guessing isn’t a strategy. https://vist.ly/4sa4e

Payer access isn’t one-size-fits-all. https://vist.ly/4s7d2See how one manufacturer used MMIT to uncover detailed payer ...
19/02/2026

Payer access isn’t one-size-fits-all. https://vist.ly/4s7d2

See how one manufacturer used MMIT to uncover detailed payer landscape insights across regions in this use case. Download the use case to learn more.

19/02/2026

Fragmented data slows access and frustrates patients. BPG Connected Intelligence unifies plan identification, coverage rules, and access intelligence into one connected layer. The result: fewer handoffs, smoother workflows, and faster starts for therapy. https://vist.ly/4s7dw

19/02/2026

With more drugs entering Medicare negotiation cycles and plan liability increasing under the redesigned Part D benefit, payers will need even tighter control over high‑cost areas. https://vist.ly/4s5rg

MMIT’s Sudhanshu Sahu takes a look at the latest research into payers’ cost management strategies.

Traditional data can only give you part of the picture. Unstructured data can be time-consuming to go through. Leveragin...
18/02/2026

Traditional data can only give you part of the picture. Unstructured data can be time-consuming to go through. Leveraging AI will help you get the full picture of the patient journey faster. https://vist.ly/4r2y7

See how leading life sciences teams are partnering with MMIT to use real-world data and AI-driven insights to improve access strategies in our latest ebook.

Read now and uncover the full picture.

18/02/2026

MMIT's Rapid Family helps you gain insight into a disruptive market event, with quick, actionable feedback from a representative sample of the payer and IDN stakeholders you care about.

Express Scripts agreed to a landmark FTC deal that aims to end the practice of preferring more expensive drugs on formularies. Will other PBMs agree to similar reforms? Find out with MMIT's industry-leading payer panel. https://vist.ly/4rzn6

“Do you have the form?” shouldn’t be the hardest question of the day. We put the right PA/ME forms exactly where HCPs al...
17/02/2026

“Do you have the form?” shouldn’t be the hardest question of the day.

We put the right PA/ME forms exactly where HCPs already are—so reps can point, tap, and go. Fewer detours. Faster starts. Happy clinics.

👉 Learn how form inclusions smooth the journey: https://vist.ly/4rusb

What happens when coverage data is consistent, structured, and standardized?• Fewer mismatches• Stronger insights• Faste...
16/02/2026

What happens when coverage data is consistent, structured, and standardized?

• Fewer mismatches
• Stronger insights
• Faster paths to access

MMIT’s BIN/PCN/Group mapping is one of those behind-the-scenes upgrades that make everything work better. Connect with us to see how. https://vist.ly/4rqt8

14/02/2026

MMIT's Rapid Family helps you gain insight into a disruptive market event, with quick, actionable feedback from a representative sample of the payer and IDN stakeholders you care about.

Express Scripts agreed to a landmark FTC deal that aims to end the practice of preferring more expensive drugs on formularies. Will other PBMs agree to similar reforms? Find out with MMIT's industry-leading payer panel. https://vist.ly/4rk8f

13/02/2026

Portfolio contracting is transforming negotiations between manufacturers, PBMs, and payers—driving deeper rebates and creating new challenges for smaller innovators. Read this blog for MMIT’s take on the evolution and future of this practice. https://vist.ly/4rfz5

When plan data is fragmented, patients feel the impact first. Coverage questions slow therapy, and manual work delays de...
12/02/2026

When plan data is fragmented, patients feel the impact first. Coverage questions slow therapy, and manual work delays decisions. https://vist.ly/4rd4v

MMIT’s BPG Connected Intelligence turns plan ID chaos into a single, connected view. HIT platforms and specialty pharmacies act faster, intervene earlier, and move patients confidently from prescription to treatment.

12/02/2026

https://vist.ly/4rbxy | How do you get a clear view of the payer landscape—across regions, plans, and policies—when the details really matter?

In this use case, see how one manufacturer partnered with MMIT to gain the granular payer insights needed to navigate access across geographies.

Address


Telephone

+12677513162

Website

Alerts

Be the first to know and let us send you an email when MMIT - Managed Markets Insight & Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MMIT - Managed Markets Insight & Technology:

Shortcuts

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Solving the What and the Why of Market Access

We leverage technology, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered. Physicians and pharmacies use our data and applications to understand what drugs are available to patients and how they are covered by health plans. Pharmaceutical manufacturers trust our data to understand how their drug and competitive drugs are covered, which helps forecast performance and tune strategy.